RETAEUR Institutional Ownership
REATA PHARMACEUTICALS INC-A
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public.
Compare plans.
Cross-institution intelligence
Institutional Research
Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.
Latest filing
Mar 10, 2022
Public consensus preview
Mixed positioning
50/100 institutional research score
1 tracked institution
Latest filing Mar 10, 2022
No institution has two comparable Schedule 13 observations yet.
Accumulating0
Unchanged0
Reducing0
Exited0
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
52-week range data is not available for this security yet.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Invesco
Mar 10, 2022 filed
Beneficial ownership filing history
Showing 2 of 2 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Invesco CIK0000914208 | Feb 28, 2022 observed Mar 10, 2022 filed · 10d Schedule 13G amendment | Exit below reporting threshold | 372.2K -1.9M | 1.20% -6.00 pts | |||
| Invesco CIK0000914208 | Dec 31, 2021 observed Feb 10, 2022 filed · 41d Schedule 13G amendment | Earliest Schedule 13G amendment found | 2.3M | 7.20% |
Explore more institutional activity
Related research
Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.